Tsirroz pecheni, kliniko-patogeneticheskie aspekty
- Autores: Yakovenko A.V1, Yakovenko E.P1, Karpova R.V1
-
Afiliações:
- Edição: Nº 13 (2012)
- Páginas: 32-36
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279737
- ID: 279737
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
In economically developed countries, liver cirrhosis (LC) is one of the six leading causes of death of patients from 35 to 60 years, accounting for 14-30 per 100,000 population. The main etiological factors of the disease are viral hepatitis B, C, D, alcohol, and drugs. The advantages and disadvantages of the morphological and non-invasive methods of diagnosis of LC are evaluated. The clinical manifestations of the disease and the mechanisms of their development are discussed in detail. Pathogenetic variants of cytolytic syndrome, and the basic mechanisms of the LC progression as the point of application of drug therapy are presented. The frequency of detection, mechanisms of development and clinical significance of intestinal dysbiosis in cirrhotic patients are emphasized.
Texto integral
Bibliografia
- Kuntz E, Kuntz H-D. Hepatology, Textbook and Atlas. Verlag: Springer Medizin Verlag Heidelberg, 2008:923.
- Григорьев П.Я., Яковенко А.В. Клиническая гастроэнтерология. М., 2004. 748 с.
- Anthony PP, Ishak KG, Nayak NC, еt al. The morphology of cirrhosis: definition, nomenclature and classification. Bull. WHO 1977;55:521-24.
- Некрасова Т. П. Морфологическое исследование в оценке степени фиброза печени // Гепатологический форум 2007. № 1. С. 11-3.
- Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 2007;47:598-607.
- Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis С. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet 1997;349:825-31.
- Шерлок Ш., Дули Д. Заболевания печени и желчных путей. Практическое руководство / Пер. с англ. / Под редакцией З.Г. Апросиной, И.А. Мухина. М., 1999. 864 с.
- Newton JL, Jones DE. Managing systemic symptoms in chronic liver disease. J Hepatol 2012;56:46-55.
- Weinstein WM, Hawkey CJ, Bosch J. Clinical Gastroenterology and Hepatology. Elsevie, 2005:1128.
- Czaja AJ. Extrahepatic immunologic features of chronic viral hepatitis. Digestive Diseases 1997;15:125-44.
- Bissel DM, Maher JJ. Hepatic fibrosis and cir rhosis. In: Zakim D, Boyer TD. (eds) Hepatology. A textbook of liver disease. 4th ed. Saunders Science (USA), 2003:395-416.
- Яковенко Э.П., Каграманова А.В., Яковенко А.В. и др. Нарушение состава кишечной микрофлоры в механизмах формирования функциональных расстройств кишечника у больных циррозом печени // Тер. архив 2012. № 2. С. 41-5.
- Almeida J, Galhenage S, Yu J, et al. Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol 2006;12(10): 1493-502.
- Murawaki, Y, Kobayashi M, Koda M, Kawasakia H. Effects о lactulose on intestinal bacterial flora and fecal organic acids in patient with liver cirrhosis. Hepatol Res 2000;17:56-64.
Arquivos suplementares
